Olga Kubassova, PhDeditorial@auntminnie.comNuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMRICNN techniques outperform conventional DL for Alzheimer's diagnosisConvolutional neural network (CNN) techniques outperform conventional deep learning (DL) methods in diagnosing Alzheimer's.Womens ImagingAbout half of women undecided on AI's use in breast imagingISMRMISMRM president outlines key highlights of the upcoming annual meeting in HonoluluMolecular ImagingSPECT/CT MPI may guide medical therapy in CAD patientsMRIAI model uses MRI data to predict brain cancer patient survival